NASDAQ:CDXS - Codexis Stock Price, Price Target & More

$11.70 +0.45 (+4.00 %)
(As of 04/24/2018 04:00 PM ET)
Previous Close$11.70
Today's Range$11.25 - $11.85
52-Week Range$3.95 - $13.60
Volume447,953 shs
Average Volume373,042 shs
Market Capitalization$584.72 million
P/E Ratio-23.40
Dividend YieldN/A
Beta-1.73

About Codexis (NASDAQ:CDXS)

Codexis logoCodexis, Inc. discovers, develops, and sells protein catalysts. It also offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides protein catalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering protein catalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.

Receive CDXS News and Ratings via Email

Sign-up to receive the latest news and ratings for CDXS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Industrial organic chemicals
Sub-IndustryBiotechnology
SectorIndustrial Products
SymbolNASDAQ:CDXS
CUSIP19200510
Phone650-421-8100

Debt

Debt-to-Equity Ratio0.02%
Current Ratio1.80%
Quick Ratio1.76%

Price-To-Earnings

Trailing P/E Ratio-23.40
Forward P/E Ratio-48.75
P/E GrowthN/A

Sales & Book Value

Annual Sales$50.02 million
Price / Sales12.32
Cash FlowN/A
Price / CashN/A
Book Value$0.51 per share
Price / Book22.94

Profitability

EPS (Most Recent Fiscal Year)($0.50)
Net Income$-22,990,000.00
Net Margins-45.97%
Return on Equity-103.42%
Return on Assets-51.64%

Miscellaneous

Employees116
Outstanding Shares52,680,000

How to Become a New Pot Stock Millionaire

Codexis (NASDAQ:CDXS) Frequently Asked Questions

What is Codexis' stock symbol?

Codexis trades on the NASDAQ under the ticker symbol "CDXS."

How were Codexis' earnings last quarter?

Codexis (NASDAQ:CDXS) announced its quarterly earnings results on Thursday, March, 8th. The biotechnology company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.05 by $0.03. The biotechnology company earned $21.70 million during the quarter, compared to analysts' expectations of $22.97 million. Codexis had a negative return on equity of 103.42% and a negative net margin of 45.97%. Codexis's revenue for the quarter was up 117.0% on a year-over-year basis. During the same period in the previous year, the company posted ($0.07) EPS. View Codexis' Earnings History.

What price target have analysts set for CDXS?

2 equities research analysts have issued 1 year price objectives for Codexis' shares. Their forecasts range from $11.00 to $12.00. On average, they anticipate Codexis' share price to reach $11.50 in the next year. View Analyst Ratings for Codexis.

Who are some of Codexis' key competitors?

Who are Codexis' key executives?

Codexis' management team includes the folowing people:
  • Mr. John J. Nicols, Pres, CEO & Director (Age 54)
  • Mr. Gordon T. B. Sangster, Sr. VP & CFO (Age 65)
  • Mr. Michael D. A. Aldridge B.Sc (Hons)., MApFin, Sr. VP of Corp. & Strategic Devel. (Age 51)
  • Dr. James J. Lalonde Ph.D., Sr. VP of R&D (Age 57)
  • Mr. Keith McKay, Director of Bus. Devel.

Has Codexis been receiving favorable news coverage?

Headlines about CDXS stock have been trending somewhat positive on Tuesday, Accern reports. The research group scores the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Codexis earned a media sentiment score of 0.21 on Accern's scale. They also gave news headlines about the biotechnology company an impact score of 43.94 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

How do I buy shares of Codexis?

Shares of CDXS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Codexis' stock price today?

One share of CDXS stock can currently be purchased for approximately $11.70.

How big of a company is Codexis?

Codexis has a market capitalization of $584.72 million and generates $50.02 million in revenue each year. The biotechnology company earns $-22,990,000.00 in net income (profit) each year or ($0.50) on an earnings per share basis. Codexis employs 116 workers across the globe.

How can I contact Codexis?

Codexis' mailing address is 200 PENOBSCOT DRIVE, REDWOOD CITY CA, 94063. The biotechnology company can be reached via phone at 650-421-8100 or via email at [email protected]


MarketBeat Community Rating for Codexis (CDXS)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  162 (Vote Outperform)
Underperform Votes:  178 (Vote Underperform)
Total Votes:  340
MarketBeat's community ratings are surveys of what our community members think about Codexis and other stocks. Vote "Outperform" if you believe CDXS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CDXS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Codexis (NASDAQ:CDXS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for Codexis in the last 12 months. Their average twelve-month price target is $11.50, suggesting that the stock has a possible downside of 1.71%. The high price target for CDXS is $12.00 and the low price target for CDXS is $11.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.002.672.75
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $11.50$11.50$8.3333$7.8125
Price Target Upside: 1.71% downside3.60% upside42.45% upside0.48% downside

Codexis (NASDAQ:CDXS) Consensus Price Target History

Price Target History for Codexis (NASDAQ:CDXS)

Codexis (NASDAQ:CDXS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/12/2018HC WainwrightSet Price TargetBuy$12.00HighView Rating Details
10/13/2017Jefferies GroupBoost Price TargetBuy$9.00 -> $11.00N/AView Rating Details
1/26/2017First AnalysisDowngradeOverweight -> Equal Weight$5.50N/AView Rating Details
1/4/2017Ladenburg ThalmannUpgradeNeutral -> Buy$6.25N/AView Rating Details
(Data available from 4/24/2016 forward)

Earnings

Codexis (NASDAQ:CDXS) Earnings History and Estimates Chart

Earnings by Quarter for Codexis (NASDAQ:CDXS)

Codexis (NASDAQ:CDXS) Earnings Estimates

2018 EPS Consensus Estimate: ($0.08)
2019 EPS Consensus Estimate: $0.05
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182($0.13)($0.05)($0.09)
Q2 20182($0.09)($0.02)($0.06)
Q3 20182($0.07)($0.02)($0.05)
Q4 20182$0.02$0.20$0.11
Q1 20191($0.07)($0.07)($0.07)
Q2 20191$0.12$0.12$0.12
Q3 20191($0.06)($0.06)($0.06)
Q4 20191$0.06$0.06$0.06

Codexis (NASDAQ CDXS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/8/2018Q4 2017$0.05$0.02$22.97 million$21.70 millionViewListenView Earnings Details
11/9/2017Q3 2017($0.16)($0.21)$10.00 million$9.98 millionViewN/AView Earnings Details
8/9/2017Q2 2017($0.13)($0.13)$9.61 million$10.30 millionViewListenView Earnings Details
5/9/2017Q1 2017($0.15)($0.18)$9.23 million$7.97 millionViewListenView Earnings Details
3/9/2017Q4 2016($0.11)($0.12)$9.15 million$10.00 millionViewListenView Earnings Details
11/8/2016Q3($0.14)$0.06$7.41 million$14.90 millionViewListenView Earnings Details
8/9/2016Q216$0.03$0.12$15.10 million$16.00 millionViewListenView Earnings Details
5/9/2016Q1($0.15)($0.11)$7.49 million$8.00 millionViewListenView Earnings Details
3/3/2016Q4($0.04)$0.02$11.63 million$11.60 millionViewN/AView Earnings Details
11/4/2015Q315($0.11)$0.13$8.85 million$17.40 millionViewListenView Earnings Details
8/11/2015Q215($0.14)($0.14)$7.34 million$6.02 millionViewListenView Earnings Details
5/7/2015Q115($0.12)($0.14)$8.00 million$6.80 millionViewListenView Earnings Details
3/3/2015Q414$0.01$0.07$13.30 million$14.20 millionViewListenView Earnings Details
11/4/2014Q314($0.06)($0.05)$9.00 million$7.47 millionViewListenView Earnings Details
8/6/2014Q214($0.15)($0.22)$8.50 million$6.60 millionViewListenView Earnings Details
5/7/2014Q114($0.10)($0.17)$10.00 million$7.10 millionViewListenView Earnings Details
3/11/2014Q413($0.21)($0.26)$10.00 million$9.50 millionViewListenView Earnings Details
11/12/2013Q313($0.31)($0.24)$8.50 million$3.90 millionViewListenView Earnings Details
8/9/2013Q2 2013($0.28)($0.33)$9.00 million$6.97 millionViewListenView Earnings Details
5/7/2013Q1 2013($0.36)($0.25)$7.63 million$11.48 millionViewListenView Earnings Details
2/27/2013Q4 2012($0.34)($0.41)$9.33 million$7.90 millionViewListenView Earnings Details
11/7/2012Q312($0.15)($0.06)$25.88 million$26.34 millionViewN/AView Earnings Details
8/9/2012($0.18)($0.15)ViewN/AView Earnings Details
5/10/2012($0.15)($0.21)ViewN/AView Earnings Details
2/7/2012($0.11)($0.15)ViewN/AView Earnings Details
11/1/2011($0.08)($0.08)ViewN/AView Earnings Details
7/28/2011($0.10)($0.14)ViewN/AView Earnings Details
5/5/2011($0.07)($0.10)ViewN/AView Earnings Details
2/3/2011($0.06)($0.01)ViewN/AView Earnings Details
10/28/2010Q3 2010($0.13)($0.08)ViewN/AView Earnings Details
8/5/2010Q2 2010($0.13)($0.15)ViewN/AView Earnings Details
5/26/2010Q1 2010($0.50)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Codexis (NASDAQ:CDXS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Codexis (NASDAQ CDXS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 9.80%
Institutional Ownership Percentage: 65.13%
Insider Trading History for Codexis (NASDAQ:CDXS)
Institutional Ownership by Quarter for Codexis (NASDAQ:CDXS)

Codexis (NASDAQ CDXS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/3/2018David V SmithDirectorSell6,000$10.37$62,220.00View SEC Filing  
3/29/2018Thomas R BaruchDirectorSell25,000$11.05$276,250.00184,670View SEC Filing  
3/27/2018Dennis P WolfDirectorSell41,666$11.15$464,575.90157,920View SEC Filing  
3/23/2018John J NicolsInsiderSell22,465$11.57$259,920.051,078,990View SEC Filing  
3/21/2018Bernard J KelleyDirectorSell10,206$12.22$124,717.32View SEC Filing  
9/14/2017Ventures Vii Affiliates F VivoMajor ShareholderSell1,060,000$5.78$6,126,800.00View SEC Filing  
8/21/2017Patrick Y YangDirectorBuy10,000$3.98$39,800.00348,234View SEC Filing  
11/15/2016Patrick Y YangDirectorBuy10,000$4.83$48,300.00320,340View SEC Filing  
9/8/2016Ventures Fund Vii L.P. VivoMajor ShareholderSell111,600$4.25$474,300.00View SEC Filing  
8/29/2016Dennis P WolfDirectorSell18,000$4.22$75,960.00132,360View SEC Filing  
8/24/2016Bernard J KelleyDirectorSell12,643$4.26$53,859.18234,906View SEC Filing  
8/16/2016Ventures Fund Vii L.P. VivoMajor ShareholderSell86,894$4.25$369,299.50View SEC Filing  
8/15/2016Vivo Ventures Vii, LlcMajor ShareholderSell50,000$4.27$213,500.00View SEC Filing  
8/4/2016Ventures Fund Vii L.P. VivoMajor ShareholderSell80,000$4.22$337,600.00View SEC Filing  
11/11/2015James LalondeSVPSell9,441$3.52$33,232.32168,011View SEC Filing  
9/11/2015Patrick Y YangDirectorBuy10,000$3.47$34,700.00290,246View SEC Filing  
9/10/2015Bernard J. KelleyDirectorSell5,200$3.45$17,940.00193,146View SEC Filing  
8/24/2015Patrick Y YangDirectorBuy10,000$3.84$38,400.00280,246View SEC Filing  
8/14/2015Patrick Y YangDirectorBuy20,000$3.97$79,400.00View SEC Filing  
6/15/2015Dennis P WolfDirectorSell35,416$4.10$145,205.60View SEC Filing  
11/18/2014Patrick Y YangDirectorBuy20,000$2.35$47,000.00View SEC Filing  
11/17/2014Patrick Y YangDirectorBuy20,000$2.34$46,800.00View SEC Filing  
8/12/2014Patrick Y YangDirectorBuy60,000$2.22$133,200.00View SEC Filing  
3/8/2013John J NicolsCEOBuy27,000$2.42$65,340.00View SEC Filing  
3/7/2013John J NicolsCEOBuy54,000$2.22$119,880.00View SEC Filing  
3/4/2013David D O'tooleCFOBuy10,000$2.02$20,200.00View SEC Filing  
11/12/2012David D O'tooleCFOBuy5,000$2.20$11,000.00View SEC Filing  
9/14/2012David D O'tooleCFOBuy5,000$2.78$13,900.00View SEC Filing  
9/14/2012Douglas T SheehySVPSell3,800$2.76$10,488.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Codexis (NASDAQ CDXS) News Headlines

Source:
DateHeadline
Head to Head Review: FutureFuel (FF) & Codexis (CDXS)Head to Head Review: FutureFuel (FF) & Codexis (CDXS)
www.americanbankingnews.com - April 24 at 11:04 PM
Porton Pharma Solutions and Codexis Launch Global PartnershipPorton Pharma Solutions and Codexis Launch Global Partnership
finance.yahoo.com - April 23 at 9:11 AM
Codexis (CDXS) Upgraded at BidaskClubCodexis (CDXS) Upgraded at BidaskClub
www.americanbankingnews.com - April 18 at 12:16 PM
Codexis (CDXS) to Post Q2 2018 Earnings of ($0.09) Per Share, Jefferies Group ForecastsCodexis (CDXS) to Post Q2 2018 Earnings of ($0.09) Per Share, Jefferies Group Forecasts
www.americanbankingnews.com - April 18 at 8:05 AM
Brokers Offer Predictions for Codexis Q1 2019 Earnings (CDXS)Brokers Offer Predictions for Codexis' Q1 2019 Earnings (CDXS)
www.americanbankingnews.com - April 17 at 6:51 AM
Codexis (CDXS) Presents At H. C. Wainwright Global Life Sciences Conference - SlideshowCodexis (CDXS) Presents At H. C. Wainwright Global Life Sciences Conference - Slideshow
seekingalpha.com - April 11 at 4:28 PM
$13.50 Million in Sales Expected for Codexis (CDXS) This Quarter$13.50 Million in Sales Expected for Codexis (CDXS) This Quarter
www.americanbankingnews.com - April 11 at 4:13 AM
 Brokerages Expect Codexis (CDXS) to Post -$0.07 Earnings Per Share Brokerages Expect Codexis (CDXS) to Post -$0.07 Earnings Per Share
www.americanbankingnews.com - April 9 at 9:14 AM
Contrasting Codexis (CDXS) & Sensient Technologies (SXT)Contrasting Codexis (CDXS) & Sensient Technologies (SXT)
www.americanbankingnews.com - April 8 at 1:30 AM
Why Codexis, Inc. Stock Is Tumbling TodayWhy Codexis, Inc. Stock Is Tumbling Today
finance.yahoo.com - April 6 at 4:39 PM
After-Hours Stock Movers 04/05: (GCAP) (OGEN) (PSMT) Higher; (CDXS) (ETH) (ORBC) Lower (more...)After-Hours Stock Movers 04/05: (GCAP) (OGEN) (PSMT) Higher; (CDXS) (ETH) (ORBC) Lower (more...)
www.streetinsider.com - April 6 at 9:56 AM
Codexis prices stock offering at $9.25; shares down 10% premarketCodexis prices stock offering at $9.25; shares down 10% premarket
seekingalpha.com - April 6 at 6:42 AM
Equities Analysts Offer Predictions for Codexis Q1 2018 Earnings (CDXS)Equities Analysts Offer Predictions for Codexis' Q1 2018 Earnings (CDXS)
www.americanbankingnews.com - April 6 at 6:39 AM
Codexis Announces Pricing of Public Offering of Common StockCodexis Announces Pricing of Public Offering of Common Stock
feeds.benzinga.com - April 5 at 10:06 PM
Codexis Announces Proposed Public Offering of Common StockCodexis Announces Proposed Public Offering of Common Stock
finance.yahoo.com - April 5 at 4:26 PM
Codexis (CDXS) Director Sells $62,220.00 in StockCodexis (CDXS) Director Sells $62,220.00 in Stock
www.americanbankingnews.com - April 5 at 1:23 PM
Codexis to Present at H.C. Wainwright Global Life Sciences Conference in Monte Carlo, MonacoCodexis to Present at H.C. Wainwright Global Life Sciences Conference in Monte Carlo, Monaco
finance.yahoo.com - April 5 at 9:00 AM
Codexis Forecasted to Earn Q3 2018 Earnings of ($0.02) Per Share (CDXS)Codexis Forecasted to Earn Q3 2018 Earnings of ($0.02) Per Share (CDXS)
www.americanbankingnews.com - April 5 at 8:41 AM
Codexis (CDXS) Upgraded to "Buy" by ValuEngineCodexis (CDXS) Upgraded to "Buy" by ValuEngine
www.americanbankingnews.com - April 3 at 5:52 PM
Codexis (CDXS) Cut to Hold at BidaskClubCodexis (CDXS) Cut to Hold at BidaskClub
www.americanbankingnews.com - March 30 at 6:14 PM
Edited Transcript of CDXS earnings conference call or presentation 8-Mar-18 9:30pm GMTEdited Transcript of CDXS earnings conference call or presentation 8-Mar-18 9:30pm GMT
finance.yahoo.com - March 30 at 4:29 PM
Codexis, Inc. (CDXS) Director Thomas R. Baruch Sells 25,000 SharesCodexis, Inc. (CDXS) Director Thomas R. Baruch Sells 25,000 Shares
www.americanbankingnews.com - March 30 at 1:14 PM
Codexis (CDXS) Lifted to "Buy" at BidaskClubCodexis (CDXS) Lifted to "Buy" at BidaskClub
www.americanbankingnews.com - March 28 at 6:32 PM
Insider Selling: Codexis, Inc. (CDXS) Director Sells 41,666 Shares of StockInsider Selling: Codexis, Inc. (CDXS) Director Sells 41,666 Shares of Stock
www.americanbankingnews.com - March 28 at 1:16 PM
$13.50 Million in Sales Expected for Codexis, Inc. (CDXS) This Quarter$13.50 Million in Sales Expected for Codexis, Inc. (CDXS) This Quarter
www.americanbankingnews.com - March 25 at 7:15 AM
Insider Selling: Codexis, Inc. (CDXS) Insider Sells 22,465 Shares of StockInsider Selling: Codexis, Inc. (CDXS) Insider Sells 22,465 Shares of Stock
www.americanbankingnews.com - March 23 at 10:14 PM
Zacks: Brokerages Anticipate Codexis, Inc. (CDXS) Will Post Earnings of -$0.12 Per ShareZacks: Brokerages Anticipate Codexis, Inc. (CDXS) Will Post Earnings of -$0.12 Per Share
www.americanbankingnews.com - March 23 at 9:30 AM
Bernard J. Kelley Sells 10,206 Shares of Codexis, Inc. (CDXS) StockBernard J. Kelley Sells 10,206 Shares of Codexis, Inc. (CDXS) Stock
www.americanbankingnews.com - March 22 at 7:32 PM
Codexis (CDXS) Rating Lowered to Sell at Zacks Investment ResearchCodexis (CDXS) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - March 14 at 7:17 PM
Codexis (CDXS) Presents At 38th Annual Cowen and Company Healthcare Conference - SlideshowCodexis (CDXS) Presents At 38th Annual Cowen and Company Healthcare Conference - Slideshow
seekingalpha.com - March 12 at 5:30 PM
Codexis (CDXS) PT Set at $12.00 by HC WainwrightCodexis (CDXS) PT Set at $12.00 by HC Wainwright
www.americanbankingnews.com - March 12 at 2:24 PM
Here's Why Codexis Dropped as Much as 14.6% TodayHere's Why Codexis Dropped as Much as 14.6% Today
finance.yahoo.com - March 9 at 5:27 PM
Codexis misses Street 4Q forecastsCodexis misses Street 4Q forecasts
finance.yahoo.com - March 9 at 10:02 AM
Codexis (CDXS) Issues Quarterly  Earnings ResultsCodexis (CDXS) Issues Quarterly Earnings Results
www.americanbankingnews.com - March 8 at 9:12 PM
Codexis Reports 2017 Fourth Quarter and Full Year Financial ResultsCodexis Reports 2017 Fourth Quarter and Full Year Financial Results
finance.yahoo.com - March 8 at 5:19 PM
Codexis Q4 Earnings PreviewCodexis Q4 Earnings Preview
feeds.benzinga.com - March 8 at 10:16 AM
Codexis Inc (NASDAQ:CDXS): Is Breakeven Near?Codexis Inc (NASDAQ:CDXS): Is Breakeven Near?
finance.yahoo.com - March 8 at 9:51 AM
$22.96 Million in Sales Expected for Codexis, Inc. (CDXS) This Quarter$22.96 Million in Sales Expected for Codexis, Inc. (CDXS) This Quarter
www.americanbankingnews.com - March 8 at 9:50 AM
Telemark Asset Management LLC Increases Stake in Codexis, Inc. (CDXS)Telemark Asset Management LLC Increases Stake in Codexis, Inc. (CDXS)
www.americanbankingnews.com - March 6 at 11:12 AM
Codexis, Inc. (CDXS) Expected to Post Earnings of $0.05 Per ShareCodexis, Inc. (CDXS) Expected to Post Earnings of $0.05 Per Share
www.americanbankingnews.com - March 6 at 3:08 AM
Codexis, Inc. (CDXS) Shares Sold by Cortina Asset Management LLCCodexis, Inc. (CDXS) Shares Sold by Cortina Asset Management LLC
www.americanbankingnews.com - February 28 at 1:27 PM
Codexis (CDXS) to Release Earnings on WednesdayCodexis (CDXS) to Release Earnings on Wednesday
www.americanbankingnews.com - February 28 at 1:24 AM
Head to Head Survey: Codexis (CDXS) vs. Biohaven Pharmaceutical (BHVN)Head to Head Survey: Codexis (CDXS) vs. Biohaven Pharmaceutical (BHVN)
www.americanbankingnews.com - February 25 at 1:18 PM
Codexis, Inc. (CDXS) Expected to Post Quarterly Sales of $22.96 MillionCodexis, Inc. (CDXS) Expected to Post Quarterly Sales of $22.96 Million
www.americanbankingnews.com - February 19 at 4:30 AM
Codexis (CDXS) Stock Rating Upgraded by Zacks Investment ResearchCodexis (CDXS) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - February 15 at 7:24 PM
Codexis Appoints Molecular Diagnostics Industry Veteran Shawn Clairmont to Lead High-Performance Enzymes CommercializationCodexis Appoints Molecular Diagnostics Industry Veteran Shawn Clairmont to Lead High-Performance Enzymes Commercialization
finance.yahoo.com - February 15 at 8:46 AM
Codexis to Present at the 25th International Molecular Medicine Tri-ConferenceCodexis to Present at the 25th International Molecular Medicine Tri-Conference
feeds.benzinga.com - February 12 at 7:43 AM
Zacks Investment Research Lowers Codexis (CDXS) to SellZacks Investment Research Lowers Codexis (CDXS) to Sell
www.americanbankingnews.com - February 9 at 7:16 PM
$0.05 EPS Expected for Codexis, Inc. (CDXS) This Quarter$0.05 EPS Expected for Codexis, Inc. (CDXS) This Quarter
www.americanbankingnews.com - January 31 at 1:20 PM
Commit To Purchase Codexis At $7.50, Earn 19.2% Annualized Using OptionsCommit To Purchase Codexis At $7.50, Earn 19.2% Annualized Using Options
www.nasdaq.com - January 24 at 4:45 PM

SEC Filings

Codexis (NASDAQ:CDXS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Codexis (NASDAQ:CDXS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Codexis (NASDAQ CDXS) Stock Chart for Tuesday, April, 24, 2018

Loading chart…

This page was last updated on 4/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.